French drug major Sanofi-Aventis posted fourth-quarter and full-year 2009 financial results this morning with sales and earnings broadly in line with expectations. Net sales for the year were up 6.3% at 29.31 billion euros ($40.06 billion), versus consensus forecasts of 29.40 billion euros. Adjusted earnings per share leapt 18.2% to 6.49 euros on a reported basis (+5.3% at constant exchange rates) vs consensus projections of 6.45 euros.
Commenting on the figures, analysts at Credit Suisse said that all key product sales were in line while other revenues were slightly higher than estimated. A 14.5% increase in vaccine R&D spend was offset by R&D cost savings elsewhere, to leave the overall charge broadly stable. SG&A spend was higher than expectations but this was offset at the bottom line by a lower than anticipated tax charge. The lower tax rate of 28% for fiscal year 2009 is as a result of a new protocol to the US-France tax treaty on dividends which took effect in December 2009 but which applies retroactively to January 1, 2009. It is unclear whether this is an ongoing issue, the analysts noted.
For the fourth quarter of 2009, total revenues came in at 7.36 billion euros, a rise of 8.9% year-on-year, with adjusted EPS at 1.37 euros, an increase of 9.6% (+18.4% CER), the company reported.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze